Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment
4.6 (254) · € 14.50 · En Stock
Aspiration pneumonia can be dangerous if left untreated. It is one of the leading causes of hospitalization and the second leading cause of death in ALS.
Frontiers Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis
Evaluation of Swallow
Pharmacist Considerations for Treating Patients With ALS
Dysphagia: current reality and scope of the problem
Frontiers Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management
Diagnosis and treatment of neurogenic dysphagia – S1 guideline of the German Society of Neurology, Neurological Research and Practice
PDF) Riluzole Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis: Texture and Compatibility with Food Thickeners Evaluation
Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration - ScienceDirect
Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis
PEG Tubes Can Play a Vital Role in ALS - TIGLUTIK (riluzole) - ALS Treatment
Evaluating Dysphagia
Tiglutik for ALS
